How much does a box of aprocitentan cost?

Aprocitentan (Aprocitentan) is a new endothelin receptor antagonist, mainly used to treat resistant hypertension, especially in patients with poor response to traditional antihypertensive drugs. Due to its unique targeting mechanism, aprecitentan has shown good antihypertensive effects in some clinical trials and has become one of the new drugs that many patients with hypertension are paying attention to. However, as of now, the drug has not been officially launched in my country. If patients need it, they usually need to obtain it through formal overseas channels.

At present, the original drug of aprexitentan is still mainly circulated in the European and American markets. The price is relatively high and it is not convenient for domestic patients to use it for a long time. However, in Laos, some pharmaceutical companies have officially launched a generic version of apremicitentan. The active ingredients of this version of the drug are consistent with the original drug, and the production quality also complies with international pharmaceutical standards. According to the latest data, the price of the Lao version of generic apremicitentan is relatively affordable, with the price of each box being around a few hundred yuan, which greatly reduces the financial burden on patients.

For domestic patients, it has become a feasible option to obtain the Laos generic version of Apremitentan through regular overseas medical platforms or overseas pharmacies. However, it is still recommended to conduct an evaluation under the guidance of a doctor before use, especially if it is used in combination with existing antihypertensive drugs. Professional guidance is required to ensure safety and effectiveness. In addition, patients should avoid purchasing medicines through informal channels to prevent buying fake medicines or inferior products, which may affect their health.

Overall, although aprecitentan is not on the market in my country, the emergence of generic drugs in Laos has provided more choices for patients in need. The price is only a fraction of the original drug and is suitable for patients who want to control their blood pressure for a long time. As time goes by, it is more likely that the drug will be launched in China in the future, and it will be more convenient to obtain the drug. At this stage, patients should make reasonable choices under the guidance of professional doctors and ensure the formality and legality of the drug purchase channels.

Reference materials:https://go.drugbank.com/drugs/DB15059